Depo-Provera Lawsuits Allege Link to Brain Cancer, Challenging Pfizer

Legal Actions Claim Popular Contraceptive Injection Increases Meningioma Risk

Recent legal actions against Pfizer, the manufacturer of the contraceptive injection Depo-Provera, allege that the drug may increase the risk of developing meningiomas, a type of brain tumor. These lawsuits contend that Pfizer failed to adequately warn users and healthcare professionals about these significant risks, potentially exposing millions of women to serious health consequences.

5 Key Points

• Lawsuits claim Depo-Provera may increase the risk of meningiomas and other brain tumors
• Kristina Schmidt filed the first lawsuit on October 1, 2024
• A March 2024 BMJ study suggests a 5.5-fold increase in meningioma risk for long-term users
• Plaintiffs allege Pfizer failed to provide adequate warnings about the risks
• Attorneys are reviewing cases nationwide on a contingency fee basis

Groundbreaking Lawsuit Challenges Contraceptive Safety

On October 1, 2024, Kristina Schmidt filed what is expected to be the first of many Depo-Provera brain tumor lawsuits. Schmidt, who used the contraceptive for approximately 17 years, was diagnosed with a brain tumor at the age of 37. Her lawsuit details a harrowing experience of side effects, including intense headaches, dizziness, and vertigo, which ultimately led to her diagnosis of Grade 1 and Grade 2 Sylvian fissure meningioma brain tumor in June 2022. The legal action asserts that the tumor was a direct consequence of the birth control injections, pointing to the active ingredient, medroxyprogesterone acetate (MPA), as a potential catalyst for abnormal cell growth leading to tumor formation.

Medical Evidence Supports Plaintiffs’ Claims

A significant study published in The BMJ in March 2024 has bolstered the plaintiffs’ arguments. The research indicated that women who have used Depo-Provera for one year or more may face a 5.5-fold increase in the risk of developing meningiomas. This alarming statistic, combined with a history of brain tumor issues reported to the FDA since the early 2000s, has prompted women previously diagnosed with these conditions to take legal action against Pfizer. The lawsuits allege that the pharmaceutical giant has long concealed the risks of meningioma associated with their product.

Get a free legal case review today

Did you develop any of the following injuries after being exposed to Fire Fighting Foam (AFFF)? * Choose one Ulcerative Colitis Kidney Cancer Pancreatic Cancer Testicular Cancer Prostate Cancer Bladder Cancer Thyroid Disease Liver Cancer Non-Hodgkin's Lymphoma None of the above Were you exposed to Fire Fighting Foam (AFFF)? *

YesNo

Which medication(s) did you take during your pregnancy? * Choose one Tylenol Acetaminophen Alka-Seltzer Coricidin Dayquil Excedrin FluTherapy Midol Mucinex Nyquil Panadol Robitussin Sinex Sudafed Theraflu Other Medication(s) Was your child diagnosed with Autism, ADHD or another condition? * Choose one Autism/Autism Spectrum Disorder (ASD) Attention Deficit Hyperactivity Disorder (ADHD) Asperger’s Syndrome Kanner’s Syndrome Childhood Disintegrative Disorder Pervasive Developmental Disorder Other Medical Condition How old was your child at the time of diagnosis? *

Under 18 years old18+ years old

Did the accident occur within the last 2 years? *

YesNo

First Name *

Last Name *

Email Address *

ZIP Code *

Phone Number *

What is your case type? * Choose one -------------------- Asbestos Baby Formula Camp Lejeune Clergy Abuse CPAP Elmiron Exactech Firefighting Foam FTX Exchange Hair Relaxer Hernia Mesh Paraquat PFAS Roundup Sex Abuse Social Media Talcum Powder Tepezza Tylenol -------------------- Birth Injury Car Accident FELA Medical Malpractice Motorcycle Accident Slip and Fall Trucking Accident Uber & Lyft Rideshare Workplace Injury Weight Loss Wrongful Death -------------------- Something Else

Human Verification *

I understand and agree that (a) submitting this form does not create an attorney-client relationship, (b) I am not already represented by an attorney for this matter, (c) the information I submit will be shared with a law firm, and (d) I have read and accepted the terms and conditions of the Privacy Policy, Terms of Service and Legal Disclaimer. Further, I consent to being contacted by a law firm or its agent after submitting this request.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Pfizer Faces Allegations of Negligence and Fraud

The lawsuits against Pfizer include a range of serious allegations, including inadequate warning, insufficient testing, flawed design, misrepresentation, fraud, and breach of warranty. Plaintiffs argue that Pfizer and other manufacturers of Depo-Provera were aware or should have been aware of the potential for the birth control injections to induce brain tumors. This claim is supported by comprehensive medical studies indicating that MPA may activate signaling pathways, resulting in atypical cell proliferation in the meninges, thereby increasing the likelihood of tumor formation.

Impact on Patients and Legal Recourse

The consequences for patients like Kristina Schmidt have been severe. Schmidt’s lawsuit outlines the complex surgical procedure required to remove her brain tumor, which involved a significant incision in the scalp and the use of a craniotome to access the skull. The surgery also necessitated the removal of a considerable section of irregular tissue surrounding the brain, replaced with bovine pericardium. Schmidt’s case highlights the serious past, present, and future harm resulting from the alleged Depo-Provera-induced brain tumor, including physical and emotional distress, ongoing medical issues, and a notable decline in overall quality of life.

Legal Landscape and Patient Advocacy

Attorneys nationwide are now reviewing Depo-Provera brain tumor lawsuits against Pfizer Inc. These legal professionals are offering free consultations and claim assessments for individuals who have received birth control injections and subsequently developed meningioma brain tumors or were diagnosed with Pseudotumor Cerebri. The lawsuits are being managed on a contingency fee basis, ensuring that clients do not incur fees or expenses unless a settlement or payout is achieved. This approach aims to provide access to legal recourse for affected individuals while holding pharmaceutical companies accountable for potential negligence in product safety and consumer information.